Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study

Abstract

Major clinical parameters and histological observations were significantly improved by the treatment with ezetimibe. Our pilot study demonstrated the efficacy of ezetimibe for drug therapy of NASH and may lead to a large-scale clinical trial in the future.